Lupron depot and Dyskinesia aggravated - a phase IV clinical study of FDA data
Summary:
Dyskinesia aggravated is reported as a side effect among people who take Lupron depot (leuprolide acetate), especially for people who are female, 30-39 old, also take Tylenol, and have Precocious puberty.
The phase IV clinical study analyzes which people have Dyskinesia aggravated when taking Lupron depot. It is created by eHealthMe based on reports of 26,734 people who have side effects when taking Lupron depot from the FDA, and is updated regularly.
What is Lupron depot?
Lupron depot has active ingredients of leuprolide acetate. It is often used in endometriosis. eHealthMe is studying from 27,037 Lupron depot users. Check the latest studies of Lupron depot.
What is Dyskinesia aggravated?
Dyskinesia aggravated (abnormality or impairment of voluntary movement) is found to be associated with 1,138 drugs and 370 conditions by eHealthMe. Check the latest studies of Dyskinesia aggravated.
26,734 people reported to have side effects when taking Lupron depot.
Among them, 13 people (0.05%) have Dyskinesia aggravated.
Among these 13 people:
What is the gender of people who have Dyskinesia aggravated when taking Lupron depot? *
- female: 83.33 %
- male: 16.67 %
What is the age of people who have Dyskinesia aggravated when taking Lupron depot? *
- 0-1: 0.0 %
- 2-9: 27.27 %
- 10-19: 18.18 %
- 20-29: 0.0 %
- 30-39: 27.27 %
- 40-49: 9.09 %
- 50-59: 0.0 %
- 60+: 18.18 %
What are other drugs people take besides Lupron depot? *
- Vitamin D3: 3 people, 23.08%
- Tylenol: 3 people, 23.08%
- Xtandi: 1 person, 7.69%
- Gabapentin: 1 person, 7.69%
- Ativan: 1 person, 7.69%
- Biotin: 1 person, 7.69%
- Cafergot: 1 person, 7.69%
- Casodex: 1 person, 7.69%
- Effexor: 1 person, 7.69%
- Eliquis: 1 person, 7.69%
What are other side effects people have besides Dyskinesia aggravated? *
- Tremor (trembling or shaking movements in one or more parts of your body): 4 people, 30.77%
- Weight Decreased: 3 people, 23.08%
- Gait Disturbance: 3 people, 23.08%
- Fatigue (feeling of tiredness): 3 people, 23.08%
- Muscle Aches (muscle pain): 3 people, 23.08%
- Nausea (feeling of having an urge to vomit): 3 people, 23.08%
- Dizziness: 3 people, 23.08%
- Crying: 2 people, 15.38%
- Headache (pain in head): 2 people, 15.38%
- Injection Site Pain: 2 people, 15.38%
What are the existing conditions these people have? *
- Precocious Puberty: 4 people, 30.77%
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 7.69%
- Parkinson's Disease: 1 person, 7.69%
- Autonomic Failure Syndrome (a degenerative disease of the autonomic nervous system): 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Lupron depot and have Dyskinesia aggravated?
- Check whether Dyskinesia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Lupron depot:
- Lupron depot (27,037 reports)
Dyskinesia aggravated treatments and more:
- Dyskinesia aggravated (46 reports)
How severe was Dyskinesia aggravated and when was it recovered:
Expand to all the drugs that have ingredients of leuprolide acetate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lupron depot:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Dyskinesia aggravated:
- Dyskinesia aggravated (1,139 drugs)
Browse all the conditions that are associated with Dyskinesia aggravated:
- Dyskinesia aggravated (370 conditions)
Related publications that referenced our studies
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Pong YH, Lu YC, Tsai VF, Huang PL, Hsieh JT, Chang HC, "Acute manic and psychotic symptoms following subcutaneous leuprolide acetate in a male patient without prior psychiatric history: A case report and literature review", Urological Science, 2014 Mar .
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Pong YH, Lu YC, Tsai VF, Huang PL, Hsieh JT, Chang HC, "Acute manic and psychotic symptoms following subcutaneous leuprolide acetate in a male patient without prior psychiatric history: A case report and literature review", Urological Science, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on leuprolide acetate (the active ingredients of Lupron depot) and Lupron depot (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Nph Iletin Ii cause Diabetes Mellitus Aggravated? - a second ago
- Could Prograf cause Ejection Fraction Decreased? - 4 seconds ago
- Drug interactions of Fuzeon and Epzicom - 7 seconds ago
- Could Zestril cause Pancreatitis? - 10 seconds ago
- Could Cephalexin cause Concomitant Disease Progression? - 13 seconds ago
- Could Coq cause Chest Pain? - 14 seconds ago
- Tolbutamide vs. Glucophage, side effect and effectiveness comparison - 15 seconds ago
- Drug interactions of Axid and Hydrochlorothiazide - 28 seconds ago
- Could Methadone Hydrochloride cause Diabetes Mellitus Non-Insulin-Dependent? - 35 seconds ago
- Could Methadone Hydrochloride cause Type 2 Diabetes? - 36 seconds ago